US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalC
CRL
Charles Riv Labs Intl Inc
171.04
4.11+2.46%After Hours: 170.41 -0.63 -0.37%17:46 03/14 EDT
OPEN/PREV CLOSE168.11/166.93
TODAY RANGE168.11-171.63
VOL1.03M
MARKET CAP8.75B
52 WEEK RANGE150.79-274.77
AVG VOL (3M)1.08M
% TURNOVER2.02%
TURNOVER--
P/E (TTM)857.77
% RANGE1.95%
EPS(TTM)0.1994
P/E(FORWARD)37.55
P/B2.527
BVPS67.69
DIVIDEND--
P/S2.160
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.66B
SHARES OUTSTANDING51.14M
NEXT EARNINGS05/07-05/12
FREE FLOAT50.62M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Short bets against S&P 500 healthcare stock rises in Feb; MRNA stays top shorted
Simply Wall St·3d ago
Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$171?
Seeking Alpha·03/04 18:57
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation
TipRanks·03/04 14:37
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
Dow Jones·03/04 11:17
Charles River Labs Raised to Neutral From Sell by Citigroup
Dow Jones·03/04 11:17
Charles River Labs Price Target Raised to $175.00/Share From $155.00 by Citigroup
Benzinga·03/04 11:07
Citigroup Upgrades Charles River to Neutral, Raises Price Target to $175
TipRanks·03/04 10:16
Charles River upgraded to Neutral from Sell at Citi
TipRanks·03/03 14:41
Dollar General downgraded, Oracle upgraded: Wall Street’s top analyst calls
TipRanks·03/03 10:35
Charles River upgraded to Neutral from Sell at Redburn Atlantic
Seeking Alpha·03/02 17:27
Play defense with Goldman's cheap healthcare picks
TipRanks·02/27 13:40
FibroBiologics and Charles River complete master cell bank for clinical trials
NASDAQ·02/26 14:32
Insiders Pile Into Holdings of FTXH ETF
Simply Wall St·02/26 12:09
Charles River Laboratories International's (NYSE:CRL) Soft Earnings Are Actually Better Than They Appear
Same Industry
Name/Symbol
Change%
Price